Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 70858 CHARLOTTE, NC

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,532,742
+$1,867,474 QoQ
Shares Held
2,597,478
+4.0% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Derivatives in RXRX

reported options exposure · as of Sep 30, 2025
CallValue
$1,464,000
CallShares
300,000
PutValue
$2,136,952
PutShares
437,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RXRX ranks #120 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,532,742 2,597,478
2026-03-31 $7,665,268 2,496,831
2025-12-31 $8,639,487 2,112,345
2025-09-30 $2,136,952 437,900
2025-09-30 $5,973,005 1,223,977
2025-09-30 $1,464,000 300,000
2025-06-30 $6,977,308 1,378,915
2025-06-30 $2,034,120 402,000
2025-06-30 $2,615,514 516,900
2025-03-31 $1,095,030 207,000
2025-03-31 $6,797,447 1,284,962
2024-12-31 $5,968,159 882,864
2024-12-31 $2,424,812 358,700
2024-09-30 $897,558 136,200
2024-09-30 $7,680,147 1,165,425
2024-06-30 $13,810,987 1,841,465
2024-03-31 $16,978,049 1,702,914
2023-12-31 $5,916 600
2023-12-31 $7,742,829 785,277
2023-09-30 $6,875,511 898,760
2023-09-30 $4,590 600
2023-06-30 $1,723,461 230,718
2023-03-31 $3,715,255 557,010
2022-12-31 $3,252,570 421,864
2022-09-30 $2,115,933 198,866
2022-06-30 $864,605 106,217
2022-03-31 $599,148 83,680
2021-12-31 $2,932,226 171,175
2021-09-30 $609,924 26,507
2021-06-30 $287,510 7,877